Brief: Sprint Bioscience Appoints New CEO

Sprint Bioscience AB

26/02/2021 08:12

Feb 26 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * SPRINT BIOSCIENCE APPOINTS ERIK KINNMAN AS NEW CEO
    * ERIK KINNMAN WILL TAKE UP ROLE ON MARCH 1
    * ERIK KINNMAN WILL SUCCEED CHARLOTTE LEIFE, WHO HAS BEEN
ACTING
CEO SINCE SEPTEMBER 1, 2021
    * ERIK KINNMAN WAS BETWEEN 2016 AND JANUARY 2021 CEO OF
ABLIVA AB
(FORMERLY NEUROVIVE)

Source text for Eikon:  ID:nWkr6wcxCM 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))